Two-day biologics drug discovery course open for registration 

Join Terrence Kenakin as he presents a two-day Applied course on September 21 and September 22 at 10AM CDT.  

This two-day course will introduce the topic of biologics as a drug therapy in addition to recombinant replacement protein biologics, peptide signalling, immunotherapy, antibodies features, and nucleotide-based therapies. The unique safety concerns associated with biologics and the challenges of pharmacokinetics will also be discussed.  

Terrence Kenakin received his doctorate in pharmacology from the University of Alberta (Edmonton, Canada) and joined The Burroughs Wellcome Fund (Research Triangle Park, NC, USA) where he spent seven years working in drug discovery. He then spent the next 25 years at GlaxoSmithKline before moving to the University of North Carolina School of Medicine where he has been a professor of pharmacology for the past six years. He has authored 10 books in the field of pharmacology and serves as the current Editor-in-Chief of the Journal of Receptors and Signal Transduction. 

Register here

Image credit: Bill Oxford

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free